Cargando…

Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease

BACKGROUND: Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) syndrome are highly prevalent respiratory conditions. Their coexistence is referred to as the overlap syndrome. They are both related to pulmonary hypertension (PH) development. This study investigated the eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Wan-Lu, Wang, Jian-Li, Jia, Guo-Hua, Mi, Wen-Jun, Liao, Yi-Xuan, Huang, Yong-Wei, Hu, Zheng, Zhang, Li-Qiang, Chen, Ya-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629366/
https://www.ncbi.nlm.nih.gov/pubmed/30973448
http://dx.doi.org/10.1097/CM9.0000000000000247
_version_ 1783435096617910272
author Sun, Wan-Lu
Wang, Jian-Li
Jia, Guo-Hua
Mi, Wen-Jun
Liao, Yi-Xuan
Huang, Yong-Wei
Hu, Zheng
Zhang, Li-Qiang
Chen, Ya-Hong
author_facet Sun, Wan-Lu
Wang, Jian-Li
Jia, Guo-Hua
Mi, Wen-Jun
Liao, Yi-Xuan
Huang, Yong-Wei
Hu, Zheng
Zhang, Li-Qiang
Chen, Ya-Hong
author_sort Sun, Wan-Lu
collection PubMed
description BACKGROUND: Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) syndrome are highly prevalent respiratory conditions. Their coexistence is referred to as the overlap syndrome. They are both related to pulmonary hypertension (PH) development. This study investigated the effects of OSA on PH in patients with COPD and the associated factors. METHODS: Consecutive patients with stable COPD were recruited for an observational cross-sectional study from September 2016 to May 2018 at Peking University Third Hospital. In total, 106 patients with COPD were enrolled and performed home portable monitoring and echocardiography. OSA was defined by an apnea hypopnea index (AHI) ≥10 events/h. Based on OSA absence or presence, patients were divided into the COPD with OSA and COPD without OSA groups. Factors affecting pulmonary artery pressure (PAP) and PH were identified using univariate analysis and logistic regression models. RESULTS: In the 106 patients with COPD, the mean age was 69.52 years, 91.5% were men, and the mean forced expiratory volume in 1 s (FEV(1)) percentage of predicted was 56.15%. Fifty-six (52.8%) patients with COPD were diagnosed with OSA, and 24 (22.6%) patients with COPD were diagnosed as PH. Compared with COPD without OSA group, the median PAP in COPD with severe OSA group increased by 5 mmHg (36.00 [26.00–50.00] mmHg vs. 31.00 [24.00–34.00] mmHg, P = 0.036). COPD with percent of night-time spent with oxygen saturation below 90% (T90) > 10% group had higher PAP than COPD with T90 ≤ 1% group (36.00 [29.00–50.00)] mmHg vs. 29.00 [25.50–34.00] mmHg, F = 7.889, P = 0.007). Univariate analysis revealed age, FEV(1)% predicted, T90, and Charlson index had statistically significant effects on PH. Multiple regression analysis showed a significant and independent effect of both FEV(1)% predicted (odds ratio [OR] = 3.46; 95% confidence interval [CI]: 1.15–10.46; P = 0.028) and AHI (OR = 3.20; 95% CI: 1.09–19.35; P = 0.034) on PH. CONCLUSIONS: Patients with COPD with OSA are more susceptible to PH, which is associated with declining lung function and increased severity of OSA. Thus, nocturnal hypoxemia and OSA in elderly patients with COPD should be identified and treated.
format Online
Article
Text
id pubmed-6629366
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-66293662019-07-22 Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease Sun, Wan-Lu Wang, Jian-Li Jia, Guo-Hua Mi, Wen-Jun Liao, Yi-Xuan Huang, Yong-Wei Hu, Zheng Zhang, Li-Qiang Chen, Ya-Hong Chin Med J (Engl) Original Articles BACKGROUND: Chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea (OSA) syndrome are highly prevalent respiratory conditions. Their coexistence is referred to as the overlap syndrome. They are both related to pulmonary hypertension (PH) development. This study investigated the effects of OSA on PH in patients with COPD and the associated factors. METHODS: Consecutive patients with stable COPD were recruited for an observational cross-sectional study from September 2016 to May 2018 at Peking University Third Hospital. In total, 106 patients with COPD were enrolled and performed home portable monitoring and echocardiography. OSA was defined by an apnea hypopnea index (AHI) ≥10 events/h. Based on OSA absence or presence, patients were divided into the COPD with OSA and COPD without OSA groups. Factors affecting pulmonary artery pressure (PAP) and PH were identified using univariate analysis and logistic regression models. RESULTS: In the 106 patients with COPD, the mean age was 69.52 years, 91.5% were men, and the mean forced expiratory volume in 1 s (FEV(1)) percentage of predicted was 56.15%. Fifty-six (52.8%) patients with COPD were diagnosed with OSA, and 24 (22.6%) patients with COPD were diagnosed as PH. Compared with COPD without OSA group, the median PAP in COPD with severe OSA group increased by 5 mmHg (36.00 [26.00–50.00] mmHg vs. 31.00 [24.00–34.00] mmHg, P = 0.036). COPD with percent of night-time spent with oxygen saturation below 90% (T90) > 10% group had higher PAP than COPD with T90 ≤ 1% group (36.00 [29.00–50.00)] mmHg vs. 29.00 [25.50–34.00] mmHg, F = 7.889, P = 0.007). Univariate analysis revealed age, FEV(1)% predicted, T90, and Charlson index had statistically significant effects on PH. Multiple regression analysis showed a significant and independent effect of both FEV(1)% predicted (odds ratio [OR] = 3.46; 95% confidence interval [CI]: 1.15–10.46; P = 0.028) and AHI (OR = 3.20; 95% CI: 1.09–19.35; P = 0.034) on PH. CONCLUSIONS: Patients with COPD with OSA are more susceptible to PH, which is associated with declining lung function and increased severity of OSA. Thus, nocturnal hypoxemia and OSA in elderly patients with COPD should be identified and treated. Wolters Kluwer Health 2019-06-05 2019-06-05 /pmc/articles/PMC6629366/ /pubmed/30973448 http://dx.doi.org/10.1097/CM9.0000000000000247 Text en Copyright © 2019 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0
spellingShingle Original Articles
Sun, Wan-Lu
Wang, Jian-Li
Jia, Guo-Hua
Mi, Wen-Jun
Liao, Yi-Xuan
Huang, Yong-Wei
Hu, Zheng
Zhang, Li-Qiang
Chen, Ya-Hong
Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
title Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
title_full Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
title_fullStr Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
title_full_unstemmed Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
title_short Impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
title_sort impact of obstructive sleep apnea on pulmonary hypertension in patients with chronic obstructive pulmonary disease
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6629366/
https://www.ncbi.nlm.nih.gov/pubmed/30973448
http://dx.doi.org/10.1097/CM9.0000000000000247
work_keys_str_mv AT sunwanlu impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease
AT wangjianli impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease
AT jiaguohua impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease
AT miwenjun impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease
AT liaoyixuan impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease
AT huangyongwei impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease
AT huzheng impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease
AT zhangliqiang impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease
AT chenyahong impactofobstructivesleepapneaonpulmonaryhypertensioninpatientswithchronicobstructivepulmonarydisease